The point mutation P467L in human receptor PPARγ has been shown to be associated with adverse effects for human health and well-being, resulting in lipodystrophy, severe insulin resistance, fatty liver, hypertension, and lowered adiponectin levels in circulation [5]. This evidence concerns the gene ADIPOQ and Insulin resistance.